{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:34:37Z","timestamp":1790778877038,"version":"4.1.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02361163"],"award-info":[{"award-number":["GR-2016-02361163"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FISM2016\/R\/31"],"award-info":[{"award-number":["FISM2016\/R\/31"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00348","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:28:03Z","timestamp":1583987283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":176,"title":["Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessia","family":"Capone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.smim.2007.10.009","article-title":"Th17 cells and mucosal host defense","volume":"19","author":"Aujla","year":"2007","journal-title":"Semin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2018.01.008","article-title":"Organ-specific mechanisms linking innate and adaptive antifungal immunity","volume":"89","author":"Drummond","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mib.2017.10.016","article-title":"Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals","volume":"40","author":"Li","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 Cell Pathway in human immunity: lessons from genetics and therapeutic interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nature08922","article-title":"IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors","volume":"464","author":"Okamoto","year":"2010","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature08114","article-title":"The AP-1 transcription factor Batf controls T(H)17 differentiation","volume":"460","author":"Schraml","year":"2009","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni1500","article-title":"The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4","volume":"8","author":"Brustle","year":"2007","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1101\/gad.8.5.538","article-title":"Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors","volume":"8","author":"Giguere","year":"1994","journal-title":"Genes Dev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e003","DOI":"10.1621\/nrs.07003","article-title":"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism","volume":"7","author":"Jetten","year":"2009","journal-title":"Nucl Recept Signal"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0378-1119(96)00504-5","article-title":"Cloning of a cDNA encoding the murine orphan receptor RZR\/ROR gamma and characterization of its response element","volume":"181","author":"Medvedev","year":"1996","journal-title":"Gene"},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/aps.2014.120","article-title":"ROR nuclear receptors: structures, related diseases, and drug discovery","volume":"36","author":"Zhang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1006\/bbrc.1994.2902","article-title":"ROR gamma: the third member of ROR\/RZR orphan receptor subfamily that is highly expressed in skeletal muscle","volume":"205","author":"Hirose","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1210\/mend.8.6.7935491","volume":"8","author":"Carlberg","year":"1994","journal-title":"Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1006\/bbrc.1993.1976","article-title":"Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences","volume":"194","author":"Becker-Andre","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.1096472","article-title":"Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells","volume":"305","author":"Eberl","year":"2004","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nchembio.1714","article-title":"Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists","volume":"11","author":"Hu","year":"2015","journal-title":"Nat Chem Biol"},{"key":"B36","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1322807111","article-title":"Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation","volume":"111","author":"Soroosh","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.immuni.2011.10.019","article-title":"Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2","volume":"36","author":"Wang","year":"2012","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/sj.onc.1210821","article-title":"P300 plays a role in p16(INK4a) expression and cell cycle arrest","volume":"27","author":"Wang","year":"2008","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature06546","article-title":"The structural basis of protein acetylation by the p300\/CBP transcriptional coactivator","volume":"451","author":"Liu","year":"2008","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","article-title":"UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development","volume":"449","author":"Agger","year":"2007","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","article-title":"The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing","volume":"130","author":"De Santa","year":"2007","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/cr.2007.83","article-title":"JMJD3 is a histone H3K27 demethylase","volume":"17","author":"Xiang","year":"2007","journal-title":"Cell Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri2487","article-title":"Epigenetic control of T-helper-cell differentiation","volume":"9","author":"Wilson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1074\/jbc.C600322200","article-title":"Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation","volume":"282","author":"Akimzhanov","year":"2007","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2007.12.006","article-title":"Regulation of T helper 17 differentiation by orphan nuclear receptors: it's not just ROR gamma t anymore","volume":"28","author":"Sundrud","year":"2008","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/s41467-019-12680-x","article-title":"NFAT primes the human RORC locus for RORgammat expression in CD4(+) T cells","volume":"10","author":"Yahia-Cherbal","year":"2019","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"27657","DOI":"10.1074\/jbc.M103426200","article-title":"A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei","volume":"276","author":"Yamazaki","year":"2001","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0083-6729(06)74012-2","article-title":"IkappaB-zeta: an inducible regulator of nuclear factor-kappaB","volume":"74","author":"Muta","year":"2006","journal-title":"Vitam Horm"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/eji.201444726","article-title":"TGF-beta converts Th1 cells into Th17 cells through stimulation of Runx1 expression","volume":"45","author":"Liu","year":"2015","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci STKE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nsmb740","article-title":"Regulation of the p300 HAT domain via a novel activation loop","volume":"11","author":"Thompson","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","article-title":"Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B58","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.1038\/ncomms15628","article-title":"JunB is essential for IL-23-dependent pathogenicity of Th17 cells","volume":"8","author":"Hasan","year":"2017","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1038\/s41598-017-17597-3","article-title":"The AP-1 transcription factor JunB is required for Th17 cell differentiation","volume":"7","author":"Yamazaki","year":"2017","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI42856","article-title":"Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice","volume":"120","author":"Biswas","year":"2010","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1228309","article-title":"A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes","volume":"338","author":"Glasmacher","year":"2012","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.4049\/jimmunol.1002750","article-title":"Cutting edge: The transcription factor Kruppel-like factor 4 regulates the differentiation of Th17 cells independently of RORgammat","volume":"185","author":"Lebson","year":"2010","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature11981","article-title":"Dynamic regulatory network controlling TH17 cell differentiation","volume":"496","author":"Yosef","year":"2013","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nmeth1068","article-title":"Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing","volume":"4","author":"Robertson","year":"2007","journal-title":"Nat Methods"},{"key":"B67","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","article-title":"The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells","volume":"40","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jnr.20995","article-title":"pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity","volume":"84","author":"Frisullo","year":"2006","journal-title":"J Neurosci Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1352458510381256","article-title":"Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood","volume":"17","author":"Edstrom","year":"2011","journal-title":"Mult Scler"},{"key":"B71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cells8060533","article-title":"Distinct expression of inflammatory features in T helper 17 cells from multiple sclerosis patients","volume":"8","author":"Capone","year":"2019","journal-title":"Cells"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1194\/jlr.M089664","article-title":"Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study","volume":"60","author":"Fellows Maxwell","year":"2019","journal-title":"J Lipid Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"16777","DOI":"10.1074\/jbc.M207999200","article-title":"Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease","volume":"278","author":"Lovato","year":"2003","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11596-012-0050-6","article-title":"Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris","volume":"32","author":"Ni","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B75","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7","article-title":"Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint","volume":"44","author":"Hollander","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1267","article-title":"An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis","volume":"35","author":"Tokuhiro","year":"2003","journal-title":"Nat Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat Genet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"B83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"22707","DOI":"10.1074\/jbc.C111.250407","article-title":"Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein","volume":"286","author":"Xu","year":"2011","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nm.4046","article-title":"Transient inhibition of ROR-gammat therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells","volume":"22","author":"Withers","year":"2016","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"37977","DOI":"10.1038\/srep37977","article-title":"Pharmacologic modulation of RORgammat translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis","volume":"6","author":"Xue","year":"2016","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/art.38272","article-title":"Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor gamma is therapeutic in the collagen-induced arthritis experimental model","volume":"66","author":"Chang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.4049\/jimmunol.1302190","article-title":"Pharmacologic inhibition of RORgammat regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo","volume":"192","author":"Skepner","year":"2014","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jdermsci.2019.03.002","article-title":"A novel RORgammat inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations","volume":"93","author":"Imura","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bcp.2018.01.023","article-title":"Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORgammat inverse agonist","volume":"150","author":"Shibata","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","article-title":"Transcription factor retinoid-related orphan receptor gammat: a promising target for the treatment of psoriasis","volume":"9","author":"Tang","year":"2018","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ejmech.2018.02.050","article-title":"Discovery of carbazole carboxamides as novel RORgammat inverse agonists","volume":"148","author":"Huang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.bmc.2018.02.018","article-title":"Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders","volume":"26","author":"Dal Pra","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1016\/j.bmcl.2017.10.027","article-title":"6-Substituted quinolines as RORgammat inverse agonists","volume":"27","author":"Barbay","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"B96","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jdermsci.2016.10.001","article-title":"Oral administration of a novel RORgammat antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17","volume":"85","author":"Takaishi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/13543776.2016.1146252","article-title":"Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)","volume":"26","author":"Ban","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"B98","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbrc.2009.01.086","article-title":"Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats","volume":"387","author":"Shankar","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543776.2017.1262350","article-title":"RORgammat inhibitors as potential back-ups for the phase II candidate VTP-43742 from vitae pharmaceuticals: patent evaluation of WO2016061160 and US20160122345","volume":"27","author":"Gege","year":"2017","journal-title":"Exp Opin Ther Pat"},{"key":"B100","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/13543776.2019.1655541","article-title":"Retinoic acid receptor-related orphan receptor gamma-t (RORgammat) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)","volume":"29","author":"Sun","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"B101","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fphar.2016.00184","article-title":"Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cytogfr.2019.10.005","article-title":"Novel activators and small-molecule inhibitors of STAT3 in cancer","volume":"49","author":"Yang","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00348\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:28:06Z","timestamp":1583987286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00348\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":103,"alternative-id":["10.3389\/fimmu.2020.00348"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00348","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"article-number":"348"}}